Axogen, Inc. Files SEC Form SC 13G/A, Statement of Beneficial Ownership By Certain Investors: (Nov. 14, 2024).
Zdroj: | Health & Medicine Week; 12/6/2024, p9482-9482, 1p |
---|---|
Abstrakt: | Axogen, Inc. filed a Form SC 13G/A with the U.S. Securities and Exchange Commission on November 14, 2024. The company's SIC code is 3845, indicating its involvement in Electromedical and Electrotherapeutic Apparatus. This filing is a formal document submitted by publicly-traded companies to the SEC, and more information can be found on the SEC's website. [Extracted from the article] |
Databáze: | Supplemental Index |
Externí odkaz: |